(+)-Tetrandrine decreases expression ISO RGD:1321856 6480464 tetrandrine results in decreased expression of ENDOG protein CTD PMID:26822499 (1->4)-beta-D-glucan multiple interactions ISO RGD:1321857 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ENDOG mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO RGD:1321857 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ENDOG mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1321857 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ENDOG mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1321856 6480464 Tetrachlorodibenzodioxin results in decreased expression of ENDOG mRNA CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ENDOG mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1321857 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ENDOG mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1321856 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ENDOG mRNA] CTD PMID:11007951 2-methylcholine affects expression ISO RGD:1321856 6480464 beta-methylcholine affects the expression of ENDOG mRNA CTD PMID:21179406 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ENDOG protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1321857 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ENDOG mRNA CTD PMID:24848799 4,4'-sulfonyldiphenol increases methylation ISO RGD:1321856 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of ENDOG gene CTD PMID:31601247 4,4'-sulfonyldiphenol affects methylation ISO RGD:1321857 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of ENDOG gene CTD PMID:31683443 4-hydroperoxycyclophosphamide increases response to substance ISO RGD:1321856 6480464 ENDOG results in increased susceptibility to perfosfamide CTD PMID:18034189 4-hydroperoxycyclophosphamide multiple interactions ISO RGD:1321856 6480464 Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of ENDOG protein], perfosfamide results in increased expression of and results in increased localization of ENDOG protein CTD PMID:18034189 4-nitrophenol increases expression ISO RGD:1321857 6480464 4-nitrophenol results in increased expression of ENDOG mRNA CTD PMID:34673133 5-fluorouracil increases expression ISO RGD:1321857 6480464 Fluorouracil results in increased expression of ENDOG protein CTD PMID:32270916 5-fluorouracil multiple interactions ISO RGD:1321857 6480464 casticin inhibits the reaction [Fluorouracil results in increased expression of ENDOG protein] CTD PMID:32270916 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ENDOG mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1321856 6480464 Acrylamide results in decreased expression of ENDOG mRNA CTD PMID:32763439 aldehydo-D-glucose multiple interactions ISO RGD:1321856 6480464 [Glucose deficiency co-treated with Acetylcysteine] affects the localization of ENDOG protein more ... CTD PMID:17309078 aldehydo-D-glucose affects localization EXP 6480464 Glucose affects the localization of ENDOG protein CTD PMID:23192364 amitrole decreases activity EXP 6480464 Amitrole results in decreased activity of ENDOG protein CTD PMID:16407272 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [cadmium acetate affects the localization of ENDOG protein] CTD PMID:24577723 arsane increases methylation ISO RGD:1321856 6480464 Arsenic results in increased methylation of ENDOG promoter CTD PMID:21291286 arsenic atom increases methylation ISO RGD:1321856 6480464 Arsenic results in increased methylation of ENDOG promoter CTD PMID:21291286 atrazine decreases expression ISO RGD:1321856 6480464 Atrazine results in decreased expression of ENDOG mRNA CTD PMID:22378314 Auriculasin multiple interactions ISO RGD:1321856 6480464 [TNFSF10 protein co-treated with auriculasin] affects the localization of ENDOG protein CTD PMID:30817944 Auriculasin affects localization ISO RGD:1321856 6480464 auriculasin affects the localization of ENDOG protein CTD PMID:30817944 bisphenol A increases expression ISO RGD:1321856 6480464 bisphenol A results in increased expression of ENDOG protein CTD PMID:21277958 bisphenol A increases expression ISO RGD:1321857 6480464 bisphenol A results in increased expression of ENDOG mRNA CTD PMID:32156529 , PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ENDOG mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ENDOG gene CTD PMID:28505145 bufalin increases expression ISO RGD:1321856 6480464 bufalin results in increased expression of ENDOG mRNA, bufalin results in increased expression of ENDOG protein CTD PMID:27444971 cadmium atom affects localization ISO RGD:1321857 6480464 Cadmium affects the localization of ENDOG protein CTD PMID:23315796 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of ENDOG promoter CTD PMID:22457795 canertinib multiple interactions ISO RGD:1321857 6480464 Canertinib inhibits the reaction [Acetaminophen results in increased transport of ENDOG protein] CTD PMID:28123000 cantharidin increases expression ISO RGD:1321856 6480464 Cantharidin results in increased expression of ENDOG protein CTD PMID:27113412 carbamazepine affects expression ISO RGD:1321856 6480464 Carbamazepine affects the expression of ENDOG mRNA CTD PMID:24752500 casticin decreases expression ISO RGD:1321856 6480464 casticin results in decreased expression of ENDOG protein CTD PMID:29098808 casticin increases expression ISO RGD:1321857 6480464 casticin results in increased expression of ENDOG protein CTD PMID:32270916 casticin multiple interactions ISO RGD:1321857 6480464 casticin inhibits the reaction [Fluorouracil results in increased expression of ENDOG protein] CTD PMID:32270916 chromium(6+) affects localization ISO RGD:1321856 6480464 chromium hexavalent ion affects the localization of ENDOG protein CTD PMID:16166740 chromium(6+) affects localization EXP 6480464 chromium hexavalent ion affects the localization of ENDOG protein CTD PMID:19459161 chrysazin increases expression ISO RGD:1321856 6480464 danthron results in increased expression of ENDOG mRNA CTD PMID:21126053 chrysazin multiple interactions ISO RGD:1321856 6480464 danthron affects the localization of and results in increased expression of ENDOG protein CTD PMID:21126053 cisplatin multiple interactions ISO RGD:1321856 6480464 [Quercetin co-treated with Cisplatin] results in increased expression of ENDOG mRNA CTD PMID:24999622 cisplatin decreases expression ISO RGD:1321856 6480464 Cisplatin results in decreased expression of ENDOG mRNA CTD PMID:27392435 clofibrate decreases expression ISO RGD:1321857 6480464 Clofibrate results in decreased expression of ENDOG mRNA CTD PMID:23811191 cobalt dichloride decreases expression ISO RGD:1321856 6480464 cobaltous chloride results in decreased expression of ENDOG mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:1321856 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ENDOG mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1321856 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ENDOG mRNA CTD PMID:20971185 copper(II) chloride increases expression ISO RGD:1321857 6480464 cupric chloride results in increased expression of ENDOG protein CTD PMID:22239859 copper(II) sulfate decreases expression ISO RGD:1321856 6480464 Copper Sulfate results in decreased expression of ENDOG mRNA CTD PMID:19549813 cycloheximide multiple interactions ISO RGD:1321856 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ENDOG mRNA] CTD PMID:11007951 cyclosporin A decreases expression ISO RGD:1321856 6480464 Cyclosporine results in decreased expression of ENDOG mRNA CTD PMID:20106945 , PMID:25562108 D-glucose multiple interactions ISO RGD:1321856 6480464 [Glucose deficiency co-treated with Acetylcysteine] affects the localization of ENDOG protein more ... CTD PMID:17309078 D-glucose affects localization EXP 6480464 Glucose affects the localization of ENDOG protein CTD PMID:23192364 deguelin decreases expression ISO RGD:1321856 6480464 deguelin results in decreased expression of ENDOG mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO RGD:1321857 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ENDOG mRNA CTD PMID:24848799 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ENDOG mRNA CTD PMID:21266533 diclofenac affects expression ISO RGD:1321856 6480464 Diclofenac affects the expression of ENDOG mRNA CTD PMID:24752500 dicrotophos decreases expression ISO RGD:1321856 6480464 dicrotophos results in decreased expression of ENDOG mRNA CTD PMID:28302478 dimethyl sulfoxide affects localization ISO RGD:1321857 6480464 Dimethyl Sulfoxide affects the localization of ENDOG protein CTD PMID:22535522 dioxygen increases expression ISO RGD:1321857 6480464 Oxygen deficiency results in increased expression of ENDOG mRNA CTD PMID:20880076 dorsomorphin multiple interactions ISO RGD:1321856 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ENDOG mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1321856 6480464 Doxorubicin results in decreased expression of ENDOG mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:1321856 6480464 Selenium results in increased expression of ENDOG mRNA CTD PMID:19244175 ellagic acid increases expression ISO RGD:1321856 6480464 Ellagic Acid results in increased expression of ENDOG protein CTD PMID:23554011 ethanol affects localization ISO RGD:1321857 6480464 Ethanol affects the localization of ENDOG protein CTD PMID:22535522 ethanol increases expression ISO RGD:1321857 6480464 Ethanol results in increased expression of ENDOG mRNA CTD PMID:30319688 fisetin increases localization ISO RGD:1321856 6480464 fisetin results in increased localization of ENDOG protein CTD PMID:28181380 folic acid multiple interactions ISO RGD:1321857 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ENDOG mRNA CTD PMID:22206623 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ENDOG mRNA CTD PMID:33387578 glucose multiple interactions ISO RGD:1321856 6480464 [Glucose deficiency co-treated with Acetylcysteine] affects the localization of ENDOG protein more ... CTD PMID:17309078 glucose affects localization EXP 6480464 Glucose affects the localization of ENDOG protein CTD PMID:23192364 hydrogen peroxide multiple interactions EXP 6480464 [Hydrogen Peroxide co-treated with 2-thiomalic acid] affects the localization of ENDOG protein CTD PMID:16407272 hydrogen peroxide affects expression ISO RGD:1321856 6480464 Hydrogen Peroxide affects the expression of ENDOG mRNA CTD PMID:21179406 isoflavones decreases expression ISO RGD:1321856 6480464 Isoflavones results in decreased expression of ENDOG mRNA CTD PMID:17374662 Lupiwighteone increases expression ISO RGD:1321856 6480464 lupiwighteone results in increased expression of ENDOG protein CTD PMID:31604113 methotrexate increases expression ISO RGD:1321857 6480464 Methotrexate results in increased expression of ENDOG mRNA CTD PMID:23836430 N-acetyl-L-cysteine multiple interactions ISO RGD:1321856 6480464 [Glucose deficiency co-treated with Acetylcysteine] affects the localization of ENDOG protein, Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of ENDOG protein] CTD PMID:17309078 , PMID:18034189 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of ENDOG protein CTD PMID:19562491 ouabain increases expression ISO RGD:1321856 6480464 Ouabain results in increased expression of ENDOG protein CTD PMID:31436044 ozone multiple interactions ISO RGD:1321857 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ENDOG mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ENDOG mRNA CTD PMID:34911549 paracetamol multiple interactions ISO RGD:1321857 6480464 [NQO1 gene mutant form results in increased susceptibility to Acetaminophen] which results in increased expression of ENDOG protein, Canertinib inhibits the reaction [Acetaminophen results in increased transport of ENDOG protein] CTD PMID:25224400 , PMID:28123000 paracetamol increases expression ISO RGD:1321857 6480464 Acetaminophen results in increased expression of ENDOG protein CTD PMID:36928416 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ENDOG mRNA CTD PMID:33387578 paracetamol increases transport ISO RGD:1321857 6480464 Acetaminophen results in increased transport of ENDOG protein CTD PMID:28123000 paracetamol decreases expression ISO RGD:1321856 6480464 Acetaminophen results in decreased expression of ENDOG mRNA CTD PMID:25704631 paracetamol affects localization ISO RGD:1321857 6480464 Acetaminophen affects the localization of ENDOG protein CTD PMID:20423716 perfluorononanoic acid decreases expression ISO RGD:1321856 6480464 perfluoro-n-nonanoic acid results in decreased expression of ENDOG mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1321857 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ENDOG mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ENDOG mRNA CTD PMID:36331819 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1321856 6480464 [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] affects the localization of ENDOG protein CTD PMID:17309078 pirinixic acid multiple interactions ISO RGD:1321856 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ENDOG mRNA CTD PMID:19710929 potassium dichromate increases expression ISO RGD:1321856 6480464 Potassium Dichromate results in increased expression of ENDOG protein CTD PMID:23718831 quercetin increases expression ISO RGD:1321856 6480464 Quercetin results in increased expression of ENDOG mRNA, Quercetin results in increased expression of ENDOG protein CTD PMID:23727915 , PMID:30152185 quercetin multiple interactions ISO RGD:1321856 6480464 [Quercetin co-treated with Cisplatin] results in increased expression of ENDOG mRNA CTD PMID:24999622 resveratrol multiple interactions ISO RGD:1321856 6480464 PD 150606 inhibits the reaction [resveratrol affects the localization of ENDOG protein] CTD PMID:20484155 resveratrol affects localization ISO RGD:1321856 6480464 resveratrol affects the localization of ENDOG protein CTD PMID:16617056 , PMID:20484155 rotenone decreases expression ISO RGD:1321856 6480464 Rotenone results in decreased expression of ENDOG mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1321856 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ENDOG mRNA CTD PMID:27188386 selenium atom increases expression ISO RGD:1321856 6480464 Selenium results in increased expression of ENDOG mRNA CTD PMID:19244175 silver atom decreases expression ISO RGD:1321857 6480464 Silver results in decreased expression of ENDOG mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1321857 6480464 Silver results in decreased expression of ENDOG mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:1321856 6480464 sodium arsenite results in decreased expression of ENDOG mRNA CTD PMID:12377979 sodium arsenite increases expression ISO RGD:1321856 6480464 sodium arsenite results in increased expression of ENDOG mRNA CTD PMID:34032870 sulforaphane increases expression ISO RGD:1321856 6480464 sulforaphane results in increased expression of ENDOG protein CTD PMID:26833863 sulindac affects localization ISO RGD:1321856 6480464 Sulindac affects the localization of ENDOG protein CTD PMID:15946692 tebufenpyrad decreases expression ISO RGD:1321856 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of ENDOG mRNA CTD PMID:33512557 tetrachloroethene decreases expression ISO RGD:1321857 6480464 Tetrachloroethylene results in decreased expression of ENDOG mRNA CTD PMID:28973375 tetracycline decreases expression ISO RGD:1321857 6480464 Tetracycline results in decreased expression of ENDOG mRNA CTD PMID:24489787 thapsigargin decreases expression ISO RGD:1321856 6480464 Thapsigargin results in decreased expression of ENDOG mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ENDOG mRNA CTD PMID:34492290 thiomalic acid multiple interactions EXP 6480464 [Hydrogen Peroxide co-treated with 2-thiomalic acid] affects the localization of ENDOG protein CTD PMID:16407272 titanium dioxide affects expression ISO RGD:1321857 6480464 titanium dioxide affects the expression of ENDOG mRNA CTD PMID:23557971 tributylstannane increases expression ISO RGD:1321857 6480464 tributyltin results in increased expression of ENDOG mRNA CTD PMID:24848799 trichostatin A increases expression ISO RGD:1321856 6480464 trichostatin A results in increased expression of ENDOG mRNA CTD PMID:24935251 Triptolide increases expression ISO RGD:1321857 6480464 triptolide results in increased expression of ENDOG protein CTD PMID:26990902 triptonide increases expression ISO RGD:1321857 6480464 triptonide results in increased expression of ENDOG mRNA CTD PMID:33045310 trovafloxacin decreases expression ISO RGD:1321857 6480464 trovafloxacin results in decreased expression of ENDOG mRNA CTD PMID:35537566 tungsten increases expression ISO RGD:1321857 6480464 Tungsten results in increased expression of ENDOG mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:1321856 6480464 Tunicamycin results in decreased expression of ENDOG mRNA CTD PMID:22378314 valproic acid decreases expression ISO RGD:1321856 6480464 Valproic Acid results in decreased expression of ENDOG mRNA CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1321856 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ENDOG mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1321856 6480464 Valproic Acid results in increased expression of ENDOG mRNA CTD PMID:26272509 valproic acid increases methylation ISO RGD:1321856 6480464 Valproic Acid results in increased methylation of ENDOG gene CTD PMID:29154799 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ENDOG mRNA CTD PMID:23034163 vitamin E increases expression ISO RGD:1321856 6480464 Vitamin E results in increased expression of ENDOG mRNA CTD PMID:19244175
